Personally, as far as cannabinoids go, I think we are approaching the last stops of the conversion train. There’s only so much one can do with these molecules, particularly if you are limited to CBD as starting point.
I think you will have to switch tracks and strive for becoming more of a fine chemical or biotech company, opening yourself up to more diverse structure space but also, a lot more regulatory oversight.
Being somewhat of a bystander, it has been very interesting to see some of the many entrepreneurs in the industry, their varied approaches to squeeze out profit from hemp biomass.
Many people have discovered the wealth of information provided in scientific journals and patents alike. This to me is a fundamental aspect of progress and innovation, being able to research as in search again.
I will not be surprised if we will see some wildly successful biotech endeavors within the next decade, endeavors that got their start as simpler hemp conversion labs.